Vr2rehab Occupational Therapist Medicare: Medicare Enrolled Practice Location: 341 Sundance Dr, Chester Springs, PA 19425 Phone: 610-445-5524 Fax: 844-464-1170 |
Mia Oboyle Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 130 Magnolia Dr, Chester Springs, PA 19425 Phone: 610-389-6191 |
Janet Lynn Rodia, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 163 Pottstown Pike, Chester Springs, PA 19425 Phone: 610-458-6464 Fax: 610-458-6465 |
Mr. Michael Robert Pechinka, MS OTRL Occupational Therapist Medicare: Medicare Enrolled Practice Location: 341 Sundance Dr, Chester Springs, PA 19425 Phone: 908-268-5061 |
Jacquelyn Repice, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 207 Flagstone Rd, Chester Springs, PA 19425 Phone: 610-241-2685 |
Jodi A Petrillo Botte Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 207 Flagstone Rd, Chester Springs, PA 19425 Phone: 610-241-2685 Fax: 877-732-7311 |
News Archive
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
In the treatment of large tumors, how effective is adoptive T cell therapy in comparison to drug-based cancer treatment? To answer this question, Dr. Kathleen Anders and Professor Thomas Blankenstein of the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch and researchers of the Beckman Research Institute of the City of Hope Cancer Center in Duarte, California, USA designed and carried out a study comparing the two methods. Based on a mouse cancer model, the researchers elucidated the mechanisms of the two different treatments.
Dr. Darja Marolt, an Investigator at The New York Stem Cell Foundation (NYSCF) Laboratory, is lead author on a study showing that human embryonic stem cells can be used to grow bone tissue grafts for use in research and potential therapeutic application. Dr. Marolt conducted this research as a post-doctoral NYSCF - Druckenmiller Fellow at Columbia University in the laboratory of Dr. Gordana Vunjak-Novakovic.
A German research team has examined data on supply and demand for blood transfusions against a computer simulation of an influenza pandemic, and discovered that a severe pandemic scenario could quickly lead to a deficit of up to 96,000 red blood cell (RBC) transfusion units in Germany alone, creating potentially fatal outcomes. Their study is published today in the journal TRANSFUSION.
› Verified 8 days ago